Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?

Could Toll-like Receptor 2 Serve as Biomarker to Detect Advanced Gastric Cancer?

Gastric cancer is one of the five most common types of cancer worldwide. Due to the heterogeneous course and the involvement of many risk factors, its treatment and diagnosis is an important challenge for modern medicine. Recent studies have emphasized the i role of Toll-like receptors (TLRs) expres...

Full description

Bibliographic Details
Main Authors:	Marek Majewski, Kamil Torres, Paulina Mertowska, Sebastian Mertowski, Izabela Korona-Głowniak, Jan Korulczyk, Witold Zgodziński, Ewelina Grywalska
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	International Journal of Molecular Sciences
Subjects:	Toll-like receptor TLR2 gastric cancer immune system
Online Access:	https://www.mdpi.com/1422-0067/24/6/5824

Similar Items

How Toll-like Receptor 9 Plays a Key Role in the Development of Gastric Cancer and Is Linked to Epstein–Barr Virus Infection
by: Marek Majewski, et al.
Published: (2023-10-01)

The Role of Toll-like Receptor 2 (TLR2) in the Development and Progression of Hashimoto’s Disease (HD): A Case Study on Female Patients in Poland
by: Maria Klatka, et al.
Published: (2023-03-01)

Unraveling the Role of Toll-like Receptors in the Immunopathogenesis of Selected Primary and Secondary Immunodeficiencies
by: Paulina Mertowska, et al.
Published: (2023-08-01)

The Importance of Toll-like Receptor 9 Expression on Monocytes and Dendritic Cells in the Context of Epstein–Barr Virus Infection in the Immunopathogenesis of Primary Glomerulonephritis
by: Iwona Smarz-Widelska, et al.
Published: (2022-10-01)

Toll-like Receptor 2 as a Marker Molecule of Advanced Ovarian Cancer
by: Małgorzata Sobstyl, et al.
Published: (2021-08-01)

Microbiota and the Immune System—Actors in the Gastric Cancer Story
by: Marek Majewski, et al.
Published: (2022-08-01)

Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis
by: Ayoub Al Othaim, et al.
Published: (2023-11-01)

Toll-Like Receptor 2 Expression as a New Hallmark of Advanced Endometriosis
by: Małgorzata Sobstyl, et al.
Published: (2020-07-01)

Scratching the Surface Takes a Toll: Immune Recognition of Viral Proteins by Surface Toll-like Receptors
by: Alexis A. Hatton, et al.
Published: (2022-12-01)

Toll-like Receptors and Thrombopoiesis
by: Xiaoqin Tang, et al.
Published: (2023-01-01)

Polymorphism in Toll-Like Receptors and <i>Helicobacter Pylori</i> Motility in Autoimmune Atrophic Gastritis and Gastric Cancer
by: Valli De Re, et al.
Published: (2019-05-01)

The Interaction Between Two Worlds: MicroRNAs and Toll-Like Receptors
by: Recep Bayraktar, et al.
Published: (2019-05-01)

Genetic polymorphisms of toll-like receptors in leprosy patients from southern Brazil
by: Priscila Saamara Masin, et al.
Published: (2022-10-01)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
by: Bettina Hoden, et al.
Published: (2023-11-01)

A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects
by: Paulina Mertowska, et al.
Published: (2021-10-01)

The role of Toll-like receptors in chemoradiotherapy-induced gastrointestinal mucositis
by: JI Ling, et al.
Published: (2021-02-01)

Surface CD200 and CD200R antigens on lymphocytes in advanced gastric cancer: a new potential target for immunotherapy
by: Witold Zgodziński, et al.
Published: (2018-05-01)

Association of toll-like receptors polymorphisms with COPD risk in Chinese population
by: Shulei Sun, et al.
Published: (2022-10-01)

Peripheral blood T lymphocytes are downregulated by the PD-1/PD-L1 axis in advanced gastric cancer
by: Witold Zgodzinski, et al.
Published: (2018-04-01)

When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment
by: Mario Wenger, et al.
Published: (2023-06-01)

Evaluation of Toll-like, chemokine, and integrin receptors on monocytes and neutrophils from peripheral blood of septic patients and their correlation with clinical outcomes
by: S.C. Silva, et al.
Published: (2014-05-01)

Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
by: Wei Gao, et al.
Published: (2017-07-01)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
by: Yang Xun, et al.
Published: (2021-10-01)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
by: Samik Chakraborty, et al.
Published: (2023-10-01)

Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
by: Valentino Le Noci, et al.
Published: (2021-09-01)

Toll-like receptor 10 (TLR10) exhibits suppressive effects on inflammation of prostate epithelial cells
by: Yu Fan, et al.
Published: (2019-01-01)

Toll-like Receptors and Prostate Cancer
by: Shu eZhao, et al.
Published: (2014-07-01)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
by: Lingling Huang, et al.
Published: (2022-06-01)

Increased Expression of Toll-Like Receptor 4 in Skin of Dogs with Discoid Lupus Erythematous (DLE)
by: Alessandro Di Cerbo, et al.
Published: (2021-04-01)

Screening and Bioinformatics Analyses of Key miRNAs Associated with Toll-like Receptor Activation in Gastric Cancer Cells
by: Xiong Huang, et al.
Published: (2023-03-01)

MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages
by: Allison M. Owen, et al.
Published: (2022-11-01)

The role of toll-like receptor 9 (TLR9) in Epstein-Barr virus-associated gastric cancer
by: Dworzanska Anna, et al.
Published: (2020-06-01)

Molecular characterization of toll-like receptor 2 gene in Bikaneri camels (Camelus dromedarius)
by: RAM KUMAR GAHLOT, et al.
Published: (2023-08-01)

The Significance of Toll-Like Receptors in the Neuroimmunologic Background of Alcohol Dependence
by: Agnieszka Czerwińska-Błaszczyk, et al.
Published: (2022-01-01)

Toll-like receptors and cancer, particularly oral squamous cell carcinoma
by: Alison Mary Rich, et al.
Published: (2014-09-01)

Decreased levels of soluble Toll-like Receptor 2 in patients with asthma
by: Mohsen Tehrani, et al.
Published: (2012-10-01)

Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes
by: Luana Chiquetto Paracatu, et al.
Published: (2020-06-01)

Toll-like receptors activation, signaling, and targeting: an overview
by: Salwa Refat El-Zayat, et al.
Published: (2019-12-01)

Association of toll-like receptors in malaria susceptibility and immunopathogenesis: A meta-analysis
by: Aína Danaisa Ramirez Ramirez, et al.
Published: (2022-04-01)

Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8+ T cell cytotoxicity in patients with gastric cancer
by: Junli Xu, et al.
Published: (2021-10-01)